755
Views
11
CrossRef citations to date
0
Altmetric
Original Article

US hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host

, , , &
Pages 227-237 | Accepted 14 Feb 2011, Published online: 24 Mar 2011

References

  • Steinbach WJ, Stevens DA, Denning DW, et al. Advances against aspergillosis. Clin Infect Dis 2003;37(Suppl 3):S155-6
  • Ader F, Nseir S, Le Berre R, et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 2005;11:427-9
  • McEvoy CE, Niewoehner DE. Adverse effects of corticosteroid therapy for COPD. A critical review. Chest 1997;111:732-43
  • Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:327-60
  • Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001;32:358-66
  • Rodrigues J, Niederman MS, Fein AM, et al. Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Am J Med 1992;93:29-34
  • Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007;30:782-800
  • Bulpa PA, Dive AM, Garrino MG, et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive. Care Med 2001;27:59-67
  • Franquet T, Muller NL, Gimenez A, et al. Semiinvasive pulmonary aspergillosis in chronic obstructive pulmonary disease: radiologic and pathologic findings in nine patients. AJR Am J Roentgenol 2000;174:51-6
  • Chandwani S, Wentworth C, Burke TA, et al. Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice. Curr Med Res Opin 2009;25:385-93
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
  • RxList - WebMD, 2009. Antifungal dosage and administration. Available at: www.rxlist.com [Last accessed 30 June 2009]
  • Dimopoulos G, Piagnerelli M, Berre J, et al. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003;15:71-5
  • Groll AH, Shah PM, Mentzel C, et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996;33:23-32
  • Meersseman W, Lagrou K, Maertens J, et al. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007;45:205-16
  • Klont RR, Meis JF, Verweij PE. Critical assessment of issues in the diagnosis of invasive aspergillosis. Clin Microbiol Infect 2001;7(Suppl 2):32-7
  • Rello J, Esandi ME, Mariscal D, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998;26:1473-5
  • von Eiff M, Roos N, Schulten R, et al. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995;62:341-7
  • Chang D, Burwell L, Lyon G, et al. Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis. Infect Control Hosp Epidemiol 2008; 29:25-30

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.